Inactive Instrument
Raptor Pharmaceutical Corp Stock
Stocks
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 61 | 25/10/2016 |
| Corporate Officer/Principal | 64 | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
BRD | Director/Board Member | 61 | 25/10/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.14% | +7.57% | +74.46% | +123.84% | 56.65B | |
| -0.49% | +6.98% | +62.88% | +67.95% | 47.49B | |
| +0.84% | +1.52% | -11.79% | -15.20% | 22.81B | |
| +2.92% | +6.29% | -3.69% | +408.67% | 21.37B | |
| +1.30% | +0.71% | +29.21% | -17.51% | 16.12B | |
| +3.20% | +9.80% | +26.27% | -34.74% | 15.56B | |
| +0.47% | -1.02% | +18.91% | +159.67% | 12.91B | |
| 0.00% | +15.02% | +133.24% | +273.89% | 12.86B | |
| +1.43% | -5.06% | +23.53% | - | 11.67B | |
| Average | +1.31% | +1.74% | +39.22% | +120.82% | 24.16B | |
| Weighted average by Cap. | +1.25% | +3.17% | +45.84% | +113.67% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
